|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of AVITA Medical (NASDAQ: RCEL) through any online brokerage.
There are no as such competitors for AVITA Medical.
The latest price target for AVITA Medical (NASDAQ: RCEL) was reported by Piper Sandler on March 2, 2021. The analyst firm set a price target for 27.00 expecting RCEL to rise to within 12 months (a possible 109.30% upside). 1 analyst firms have reported ratings in the last year.
The stock price for AVITA Medical (NASDAQ: RCEL) is $12.9 last updated Fri Dec 03 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for AVITA Medical.
AVITA Medical’s $Q2 earnings are confirmed for after-market on February 10, 2022.
There is no upcoming split for AVITA Medical.
AVITA Medical is in the sector and industry. They are listed on the NASDAQ.